(Q38083603)

28 August 2017

title

Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes (English)

1 reference

28 August 2017

0 references

1 reference

Jan Peter Yska

1

1 reference

28 August 2017

Susanne van der Linde

2

1 reference

28 August 2017

Véronique V Tapper

3

1 reference

28 August 2017

Jan A Apers

4

1 reference

28 August 2017

Marloes Emous

5

1 reference

28 August 2017

Erik R Totté

6

1 reference

28 August 2017

Bob Wilffert

7

1 reference

28 August 2017

Eric N van Roon

8

1 reference

28 August 2017

publication date

1 June 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

23

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

819-825

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-013-0882-6

28 August 2017

exact match

0 references

cites work

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

A systematic review of drug absorption following bariatric surgery and its theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Altered drug disposition in obesity and after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Medication and nutrient administration considerations after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Prompt reduction in use of medications for comorbid conditions after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Investigation of antidepressant medication usage after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Nursing challenges in the administration of oral antidepressant medications in gastric bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Health benefits of gastric bypass surgery after 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery--who fails in the early postoperative course?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Medication use patterns after gastric bypass surgery for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m²

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Health care use during 20 years following bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Effect of gastric bypass surgery on the absorption and bioavailability of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Medication use after bariatric surgery in a managed care cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

The impact of bariatric surgery on comorbidities and medication use among obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

The effects of bariatric surgery on asthma severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Respiratory medication prescriptions before and after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Impact of bariatric surgery on female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Contraceptive treatment after biliopancreatic diversion needs consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Challenging oral contraception after weight loss by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Contraceptive use among women with a history of bariatric surgery: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Nutritional and pharmacologic challenges in the bariatric surgery patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-0882-6

Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year

21 January 2018

1 reference

12 December 2020

Surgery for obesity in adulthood

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient

1 reference

12 December 2020

Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery

1 reference

12 December 2020

Reduction in prescription medication costs after laparoscopic gastric bypass

1 reference

12 December 2020

Influence of several surgical techniques in peptic ulcer disease on the oral kinetic of a basic drug

1 reference

12 December 2020

Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study

1 reference

12 December 2020

10.1007/S11695-013-0882-6

Identifiers

DOI

1 reference

28 August 2017

1 reference